Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Regenyal Laboratories is an Italian biotechnology company specializing in the research, development, and manufacturing of hyaluronic acid-based medical devices for aesthetic medicine and orthopedics. The company is widely recognized for its proprietary "Green Injections" international standard, which prioritizes high-purity raw materials and environmentally sustainable production processes to ensure maximum product safety and biocompatibility. Their flagship product portfolio includes the Regenyal Idea, Bio-Expander, and Super Idea dermal fillers, which are designed for various applications from superficial skin biorevitalization to deep facial volume restoration. Regenyal also produces specialized intra-articular injections for treating joint conditions, leveraging advanced cross-linking technologies to enhance product longevity and performance. Based in San Benedetto del Tronto, the company maintains rigorous quality control through its own internal manufacturing facilities and clinical research collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Regenyal Laboratories.